• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Medicine PAC (Political Action Committee) Launches in Washington

Microdose NewsDesk by Microdose NewsDesk
March 23, 2023
in Law & Politics
Reading Time: 3 mins read
A A
Psychedelic Medicine PAC (Political Action Committee) Launches in Washington

“A political action committee (PAC) is a political committee that pools campaign contributions from members and donates those funds to campaigns for or against candidates, ballot initiatives, or legislation.”

Like them or not, PACs are a reality of legislative life in America — and psychedelic medicine now has its own voice in Washington. 

The Psychedelic Medicine PAC is a Political Action Committee intending to help elect leaders who believe in science and want to improve lives through psychedelic medicine. 

With decrim and reform measures gaining steam at the state and federal level, the Psychedelic Medicine PAC aims to help push things forward. We’ll take all the help we can get.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

See their mission statement and press release below.

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

For more information or to donate, check out their website and social media.

 

 

 

 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Psychedelic Medicine Coalition (PMC) is excited to announce our newest initiative to catalyze change in Washington: Psychedelic Medicine PAC. PM PAC is a Political Action Committee intending to help elect leaders who believe in science and want to improve lives through psychedelic medicine. 

“I am thrilled to announce the launch of our political action committee dedicated to advancing the science of psychedelic medicine for the betterment of American society,” said PM PAC President and Co-Founder and Chief Executive Officer of Psychedelic Medicine Coalition, Melissa Lavasani. “With the growing evidence of therapeutic benefits from psychedelics, we

Purchase Official Lasix

believe it is time for the American people to take action into their own hands by electing leaders that support policies that expand access to these life-changing treatments. We look forward to working with policy leaders and organizations to create positive change and bring the benefits of psychedelic medicine to those in need.” 

The launch of PM PAC is crucial in the fight to change legislation around psychedelics and supplements the PMC’s work in Washington and other organizations’ efforts. America can no longer afford leaders who ignore scientific evidence, and it’s time for action and change. 

“It’s time for Congress to recognize the healing of these medicines and commit to funding the research to continue the progress,” said Ryan Rodgers, Executive Director and Co-Founder of PM PAC, President of The Strategy Group Company, and Executive Director of the REID Foundation. “These medicines can help those struggling with PTSD, addiction, anxiety, and depression, among other ailments — and should be recognized as such, especially by our policymakers.” 

The launch of the Psychedelic Medicine PAC is a call to action for all Americans who want to see positive change in their communities. By electing leaders who prioritize science and understand the value of psychedelic medicines, we can improve the lives of millions of Americans struggling with various ailments. It’s time to take action, and the Psychedelic Medicine PAC is here to help

CONTACT INFORMATION 

info@psychedelicmedicinepac.com 

Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
F.I.V.E. Clinical: Developing Standards of Care for 5-MeO-DMT

F.I.V.E. Clinical: Developing Standards of Care for 5-MeO-DMT

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.